ROSLYN MOODLEY: Open Payments
NPI 1386075125 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$456 in 11 payments from 8 companies in 2025. Trend: 2023 $562 · 2024 $397 · 2025 $456
Food & beverage: $406Education: $50
| Company | Payments | Amount |
|---|---|---|
| Aroa Biosurgery Incorporated | 1 | $116 |
| Haemonetics Corporation | 1 | $108 |
| ABBVIE INC. | 3 | $63 |
| W. L. Gore & Associates, Inc. | 1 | $50 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $43 |
| Mallinckrodt Hospital Products Inc. | 1 | $26 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| Teleflex LLC | 1 | $23 |
Products named: TEG6S HEMOSTASIS SYSTEM, GORE-TEX Vascular Graft, XIFAXAN, AVYCAZ, TERLIVAZ, ZERBAXA, TEFLARO, QUIKCLOT.
Industry payments across TX — which companies pay providers there.
